MedicaidCoverageMedium impact
Coverage of Buprenorphine Injection –REVISED May 13, 2020
Maryland Medicaid·MD · Psychiatry, Pain Management, Family Medicine +1 more·Provider Transmittal
Effective date
May 13, 2020
We identified it
Jun 20, 2026
Summary
Maryland Medicaid has revised their coverage policy for buprenorphine injection treatments used in opioid use disorder therapy. This policy update specifically affects billing and coverage requirements for injectable buprenorphine products under the Maryland Medicaid program.
Action Required
Billing team should review the revised Maryland Medicaid transmittal document to understand updated coverage criteria and billing requirements for buprenorphine injection services. Verify current billing practices align with revised policy requirements and update encounter forms if necessary for Maryland Medicaid patients receiving buprenorphine injections.